SEC Filing Summary: GSK Plc Form 6-K
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated November 15, 2023, reports on the status of three employee share schemes for the six-month period from May 1, 2023, to October 31, 2023. The document serves as a Block Listing Six Monthly Return required under UK Listing Rules.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the number of securities allotted and unallotted under specific share plans.
Material Changes and Scheme Activity
- 2017 Deferred Annual Bonus Plan: No securities were issued or allotted during the period. The balance of unallotted securities remained at 271,307.
- Share Save Plan 2012: 52,231 securities were issued/allotted. The unallotted balance decreased from 558,829 to 506,598.
- Share Save Plan 2022: 845 securities were issued/allotted. The unallotted balance decreased from 999,954 to 999,109.
- Total Issuance: A total of 53,076 securities were issued across all schemes during the reporting period.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a statutory return regarding share scheme administration.
Key Facts for Investor Verification
- Verify the total number of shares issued (53,076) against the company's treasury stock or authorized share count.
- Confirm the remaining unallotted balances for the 2012 and 2022 Share Save Plans (506,598 and 999,109 respectively) to assess future dilution potential.
- Note that no new shares were added to the block schemes during this period.